The MIA-T procedure is intended to replicate a surgical annuloplasty procedure on the end of a catheter, reducing annular area and ultimately reducing tricuspid regurgitation. The animation …

MID develops products for Transcatheter Cardiac Repair (TCR) percutaneously replicating surgical procedures with the aim of eliminating the need for open heart surgery! Patient: …

May 27, 2021—Micro Interventional Devices (MID) has received FDA Breakthrough Device designation for its MIA-T percutaneous tricuspid minimally invasive annuloplasty system. The …

2021年5月27日 · MID develops proprietary Transcatheter Cardiac Repair (TCR) technologies addressing unmet needs in the treatment of structural heart disease. The company's products …

2021年7月22日 · The MIA-T Polymer-Based Percutaneous Tricuspid Annuloplasty System: Technology Description and Early Human Clinical Data Presenter: Mathew Williams July 22, …

View the profiles of people named Mia T. Join Facebook to connect with Mia T and others you may know. Facebook gives people the power to share and makes...

13K Followers, 2,580 Following, 98 Posts - Mia.T (@mieeyaaa) on Instagram: "brb, chasing my dreams. 🦋 🎶Music Major | 🧠 Psych & Neuroscience Minor 🎤 @nigenite"

💌click here! 📩💖welcome to my channel! hi I'm mia! I post lifestyle, drawing, crafts, and more random things ⭐️ fav animals: koalas, pandas, and lots, LOT...

2021年5月27日 · The MIA-T system treats moderate-severe tricuspid regurgitation (TR) via a 12F catheter-based system. MID develops proprietary Transcatheter Cardiac Repair (TCR) …